201 related articles for article (PubMed ID: 19048595)
21. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
22. Identification of Smyd4 as a potential tumor suppressor gene involved in breast cancer development.
Hu L; Zhu YT; Qi C; Zhu YJ
Cancer Res; 2009 May; 69(9):4067-72. PubMed ID: 19383909
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
24. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
25. A synthetic planar cell polarity system reveals localized feedback on Fat4-Ds1 complexes.
Loza O; Heemskerk I; Gordon-Bar N; Amir-Zilberstein L; Jung Y; Sprinzak D
Elife; 2017 Aug; 6():. PubMed ID: 28826487
[TBL] [Abstract][Full Text] [Related]
26. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
27. MiR-106b-5p regulates the migration and invasion of colorectal cancer cells by targeting FAT4.
Pan M; Chen Q; Lu Y; Wei F; Chen C; Tang G; Huang H
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33063118
[TBL] [Abstract][Full Text] [Related]
28. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
[TBL] [Abstract][Full Text] [Related]
29. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
[TBL] [Abstract][Full Text] [Related]
30. SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer.
Zeller C; Hinzmann B; Seitz S; Prokoph H; Burkhard-Goettges E; Fischer J; Jandrig B; Schwarz LE; Rosenthal A; Scherneck S
Oncogene; 2003 May; 22(19):2972-83. PubMed ID: 12771949
[TBL] [Abstract][Full Text] [Related]
31. PTEN deficiency: a role in mammary carcinogenesis.
Petrocelli T; Slingerland JM
Breast Cancer Res; 2001; 3(6):356-60. PubMed ID: 11737885
[TBL] [Abstract][Full Text] [Related]
32. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.
Xu XL; Wu LC; Du F; Davis A; Peyton M; Tomizawa Y; Maitra A; Tomlinson G; Gazdar AF; Weissman BE; Bowcock AM; Baer R; Minna JD
Cancer Res; 2001 Nov; 61(21):7943-9. PubMed ID: 11691816
[TBL] [Abstract][Full Text] [Related]
34. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
[TBL] [Abstract][Full Text] [Related]
35. ErbB2-positive mammary tumors can escape PI3K-p110α loss through downregulation of the Pten tumor suppressor.
Simond AM; Rao T; Zuo D; Zhao JJ; Muller WJ
Oncogene; 2017 Oct; 36(43):6059-6066. PubMed ID: 28783168
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development.
Mao Y; Mulvaney J; Zakaria S; Yu T; Morgan KM; Allen S; Basson MA; Francis-West P; Irvine KD
Development; 2011 Mar; 138(5):947-57. PubMed ID: 21303848
[TBL] [Abstract][Full Text] [Related]
37. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
38. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
39. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
[TBL] [Abstract][Full Text] [Related]
40. Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.
Chander H; Brien CD; Truesdell P; Watt K; Meens J; Schick C; Germain D; Craig AW
Breast Cancer Res; 2014 Dec; 16(6):3413. PubMed ID: 25547174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
